Bellerophon Therapeutics Inc buy Slaandjivaa
Start price
12.04.17
/
50%
€16.13
Target price
12.10.17
€40.59
Performance (%)
38.42%
End price
12.10.17
€22.32
Summary
This prediction ended on 12.10.17 with a price of €22.32. With a performance of 38.42% the BUY prediction by Slaandjivaa was a big success. Slaandjivaa has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bellerophon Therapeutics Inc | - | - | - | - |
iShares Core DAX® | 1.280% | 1.027% | 11.234% | 16.273% |
iShares Nasdaq 100 | -2.457% | -4.650% | 23.181% | 39.418% |
iShares Nikkei 225® | -2.006% | -2.091% | 6.745% | 6.545% |
iShares S&P 500 | -0.662% | -1.246% | 22.521% | 40.218% |
Comments by Slaandjivaa for this prediction
In the thread Bellerophon Therapeutics Inc diskutieren
Slaandjivaa stimmt der Buy-Einschätzung von datca zu
Slaandjivaa stimmt am 12.04.2017 der Buy-Einschätzung von datca mit dem Kursziel 3$ zu.Überschrift: Bellerophon, erfolgreich tätig im Markt der Pulmonary Arterial Hypertension
(Laufzeit überschritten)